Sg Americas Securities, LLC Oncorus, Inc. Transaction History

Sg Americas Securities, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$0.28 - $0.45 $15,073 - $24,224	53,833 Added 74.06%	126,525 $44,000
Q4 2022 Feb 02, 2023	BUY	$0.24 - $0.76 $8,725 - $27,629	36,355 Added 100.05%	72,692 $18,000
Q3 2022 Oct 31, 2022	BUY	$0.85 - $1.65 $19 - $37	23 Added 0.06%	36,337 $31,000
Q2 2022 Jul 29, 2022	SELL	$1.04 - $1.86 $4,558 - $8,152	-4,383 Reduced 10.77%	36,314 $46,000
Q1 2022 Apr 29, 2022	SELL	$1.44 - $5.62 $442 - $1,725	-307 Reduced 0.75%	40,697 $72,000
Q4 2021 Feb 07, 2022	SELL	$5.03 - $11.63 $34,440 - $79,630	-6,847 Reduced 14.31%	41,004 $216,000
Q3 2021 Nov 01, 2021	BUY	$9.29 - $14.27 $125,795 - $193,230	13,541 Added 39.47%	47,851 $447,000
Q2 2021 Aug 12, 2021	SELL	$13.3 - $17.3 $8,485 - $11,037	-638 Reduced 1.83%	34,310 $473,000
Q1 2021 May 13, 2021	BUY	$11.89 - $35.55 $307,297 - $918,789	25,845 Added 283.92%	34,948 $486,000
Q4 2020 Feb 04, 2021	BUY	$15.0 - $35.15 $136,545 - $319,970	9,103 New	9,103 $294,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.